Fall 2021 Meeting of the MedInvest Oncology Investor Conference Series to be Hosted Dec 7-10

Conference.jpg

The Fall Meeting of the MedInvest Oncology Investor Conference Series will be hosted on December 7-10, 2021.  The National Cancer Institute will be the Presenting Partner.

 

The event will feature keynote talks, panels, and corporate presentations from over 50 companies in the cancer space.  Over 150 investors spanning venture capital, public funds, foundations, family offices and government grant making entities are expected to attend.

 

Conference speakers include:

Dr. Ronald DePinho – Former CEO, MD Anderson Cancer Center
Dr. Roy Herbst – Director of Medical Oncology at Yale Cancer Center | Former Director Yale Cancer Center
Dr. Christiana Bardon - Partner, MPM Capital and MPM Oncology Impact Fund | Board Member, AACR
Dr. Wei Zhang - Director, Center for Cancer Genomics and Precision Oncology, Wake Forest Baptist Comprehensive Cancer Center
Dr. Brian Leyland-Jones - Former Director of Emory and McGill Cancer Centers | Director, The Darwin Foundation
Dr. Alfred Slanetz – CEO, Geneius Biotechnology | Former CEO, Bluebird Bio
Dr. Abe Heifets – CEO, Atomwise
Dr. Corrie Painter - Associate Director of the Broad Institute Cancer Program | Associate Director of Count Me In
Dr. Phil Freidlander - Professor, Mt. Sinai
Dr. Michael Salgaller - Director of Tech Transfer, NCI | Supervisor, Invention Development and Marketing Unit (IDMU)
Steven Ferguson - Deputy Director, Licensing and Entrepreneurship, National Institutes of Health

To register for the conference, please go HERE.